Tradestie Institutional Equity Comparison Engine · Market Close Oct 29, 2026

ATON vs LNAI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ATON Wins Head-to-Head Institutional Verdict (2–2 across 6 Pillars · 4–0 Matrix Metrics)

ATON Overall Winner 6-Pillar Tally: ATON 2 – 2 LNAI (2 Tie) Matrix Metrics: ATON 4 – 0 LNAI

As of Oct 29, 2026, AlphaTON Capital Corp. (ATON) is the stronger overall head-to-head candidate over Lunai Bioworks Inc. (LNAI) in the Tradestie Institutional Equity Comparison Engine, winning 4–0 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Options & Positioning). ATON carries a Unified Composite Score of 45.1/100 (HOLD) at $0.32 (N/M Forward P/E, 0.0% operating margin), whereas LNAI carries 44.1/100 (HOLD) at $0.16 (N/M Forward P/E, -6888.6% operating margin).

  • Technical & Structure Timing Caution: ATON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.3); meanwhile LNAI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 13.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ATON vs LNAI
ATON NASDAQ Head-to-Head Winner
AlphaTON Capital Corp. Common Stock
Finance Services
$0.32
+0.0% 1D
Market Cap $7.5M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.90β · 65% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 45.0 Fund 46.0 Flow 50.0 Mom 35.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -31.2%), weak momentum, RSI 41
RSI-14: 41.3 · SMA20: $0.32 · SMA50: $0.38
LNAI NASDAQ
Lunai Bioworks Inc. Common Stock
Pharmaceutical Preparations
$0.16
-30.2% 1D
Market Cap $1.2M
TTM Revenue $51,992
Forward P/E N/M
Beta / 30D Vol 3.92β · 186% Vol
Unified Composite Score
44.1 / 100 HOLD
Tech 45.0 Fund 43.0 Flow 43.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -27.8%), weak momentum, RSI 13
RSI-14: 13.3 · SMA20: $0.74 · SMA50: $1.61

6-Pillar Scorecard Institutional Category Breakdown (ATON 2 – 2 LNAI)

Columns: Metric · ATON · LNAI
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale LNAI
Revenue Growth (YoY) +0.0% +0.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A $51,992
Market Cap $7.5M $1.2M
3. Profitability & Quality ATON
Gross Margin N/A 100.0%
Operating Margin 0.0% -6888.6%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -311.0% -325.5%
4. Balance Sheet & Cash Flow LNAI
Cash Generation (TTM) N/A -$7.8M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage $1.67 Book/Sh · -311.0% ROE $1.7M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ATON
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 0.1% (50th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Asset Management Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ATON (4) vs LNAI (0)
Institutional Metric ATON LNAI Criterion Row Edge
Market Capitalization
Scale
$7.5M $1.2M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% +0.0% Higher Growth Tie
Operating Margin (TTM)
Profitability
0.0% -6888.6% Higher Margin ATON
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-311.0% -325.5% Higher ROE ATON
52-Week Range Position
Momentum
0% ($0–$14) 0% ($0–$5) Stronger Trend Tie
Beta / 30D Volatility
Risk Regime
1.90β · 65% Vol 3.92β · 186% Vol Lower Realized Risk ATON
Unified Institutional Score
Composite Signal
45.1 / 100 (HOLD) 44.1 / 100 (HOLD) Higher Composite ATON
Trailing 12M Revenue (USD)
Operating Scale
N/A $51,992 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($1.67 Book/Sh · -311.0% ROE) -$7.8M EBITDA ($1.7M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ATON +4.98 pp
ATON: -6.71% · LNAI: -11.69%
3M Horizon ATON +5.9 pp
ATON: -57.35% · LNAI: -63.25%
6M Horizon LNAI +26.49 pp
ATON: -93.8% · LNAI: -67.31%
1Y Horizon LNAI +26.49 pp
ATON: -93.8% · LNAI: -67.31%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ATON vs LNAI. Trailing 12-month operating profitability (ATON 0.0% vs LNAI -6888.6%) and valuation multiples (ATON N/M vs LNAI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ATON ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-311.0% · N/M
LNAI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$51,992
Gross Margin100.0%
Op. Margin-6888.6%
ROE / Fwd P/E-325.5% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ATON UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ATON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LNAI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 0.1%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LNAI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ATON Moat Profile Cyclical / Execution-Driven Positioning
Asset Management Operator
Competes within the Asset Management value chain with $7.5M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
LNAI Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.2M market capitalization and -6888.6% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ATON vs LNAI Key Questions & Quantitative Answers

As of Oct 29, 2026, AlphaTON Capital Corp. (ATON) is the stronger overall head-to-head candidate over Lunai Bioworks Inc. (LNAI) in the Tradestie Institutional Equity Comparison Engine, winning 4–0 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Options & Positioning). ATON carries a Unified Composite Score of 45.1/100 (HOLD) at $0.32 (N/M Forward P/E, 0.0% operating margin), whereas LNAI carries 44.1/100 (HOLD) at $0.16 (N/M Forward P/E, -6888.6% operating margin). Technical & Structure Timing Caution: ATON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.3); meanwhile LNAI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 13.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

LNAI leads the Growth & Scale pillar: ATON posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with LNAI at +0.0% YoY revenue growth and +0.0% YoY earnings growth on $51,992 TTM revenue (100.0% gross margin, -6888.6% operating margin). On trailing 12-month operating scale, ATON generates N/A in USD-normalized revenue versus $51,992 for LNAI. In operating R&D and SG&A reinvestment, ATON deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LNAI.

ATON and LNAI trade at balanced relative valuation multiples. ATON trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas LNAI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ATON (-311.0% ROE) versus LNAI (-325.5% ROE) capital efficiency.

In options market volatility and institutional positioning, ATON carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.90β · 65% Vol realized risk). By comparison, LNAI carries 0.1% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.92β · 186% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Oct 29, 2026. For educational research only; not investment advice.